Effect of Inactivation Methods on SARS-CoV-2 Virion Protein and Structure

The risk posed by Severe Acute Respiratory Syndrome Coronavirus -2 (SARS-CoV-2) dictates that live-virus research is conducted in a biosafety level 3 (BSL3) facility. Working with SARS-CoV-2 at lower biosafety levels can expedite research yet requires the virus to be fully inactivated. In this study...

Descripción completa

Detalles Bibliográficos
Autores principales: Loveday, Emma K., Hain, Kyle S., Kochetkova, Irina, Hedges, Jodi F., Robison, Amanda, Snyder, Deann T., Brumfield, Susan K., Young, Mark J., Jutila, Mark A., Chang, Connie B., Taylor, Matthew P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8066162/
https://www.ncbi.nlm.nih.gov/pubmed/33810401
http://dx.doi.org/10.3390/v13040562

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8066162/
https://www.ncbi.nlm.nih.gov/pubmed/33810401
http://dx.doi.org/10.3390/v13040562

Ejemplares similares